Ormond Beach, FLORIDA2 Active Studies

Multiple Sclerosis Clinical Trials in Ormond Beach, FLORIDA

Find 2 actively recruiting multiple sclerosis clinical trials in Ormond Beach, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,568
Enrolling

Recruiting Multiple Sclerosis Studies in Ormond Beach

About Multiple Sclerosis Clinical Trials in Ormond Beach

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 2 multiple sclerosis clinical trials recruiting participants in Ormond Beach, FLORIDA. These studies are seeking a combined 1,568 participants. Research is being sponsored by Immunic AG, Sandoz. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Ormond Beach — FAQ

Are there multiple sclerosis clinical trials in Ormond Beach?

Yes, there are 2 multiple sclerosis clinical trials currently recruiting in Ormond Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ormond Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ormond Beach research site will contact you about next steps.

Are clinical trials in Ormond Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ormond Beach studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 2 active trials in Ormond Beach are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov